Shaikh M Rahman1, Karalee C Baquero2, Mahua Choudhury3, Rachel C Janssen2, Becky A de la Houssaye2, Ming Sun4, Shinobu Miyazaki-Anzai5, Shu Wang4, Naima Moustaid-Moussa4, Makoto Miyazaki5, Jacob E Friedman6. 1. Department of Nutritional Sciences, Texas Tech University, Lubbock, TX, USA. Electronic address: Shaikh.rahman@ttu.edu. 2. Departments of Pediatrics, University of Colorado Denver, Aurora, CO, USA. 3. Pharmaceutical Sciences, Irma Lerma Rangel College of Pharmacy, Texas A&M Health Science Center, Kingsville, TX, USA. 4. Department of Nutritional Sciences, Texas Tech University, Lubbock, TX, USA. 5. Renal and Hypertension, University of Colorado Denver, Aurora, CO, USA. 6. Departments of Pediatrics, University of Colorado Denver, Aurora, CO, USA; Biochemistry and Molecular Genetics, University of Colorado Denver, Aurora, CO, USA.
Abstract
BACKGROUND AND OBJECTIVE: Atherosclerosis is both a chronic inflammatory disease and a lipid metabolism disorder. C/EBPβ is well documented for its role in the development of hematopoietic cells and integration of lipid metabolism. However, C/EBPβ's role in atherosclerotic progression has not been examined. We assessed the impact of hematopoietic CEBPβ deletion in ApoE(-/-) mice on hyperlipidemia, inflammatory responses and lesion formation in the aorta. METHODS AND RESULTS: ApoE(-/-) mice were reconstituted with bone marrow cells derived from either WT or C/EBPβ(-/-) mice and placed on low fat or high fat/high cholesterol diet for 11 weeks. Hematopoietic C/EBPβ deletion in ApoE(-/-) mice reduced blood and hepatic lipids and gene expression of hepatic stearoyl CoA desaturase 1 and fatty acid synthase while expression of ATP binding cassette transporter G1, cholesterol 7-alpha-hydroxylase, and liver X receptor alpha genes were significantly increased. ApoE(-/-) mice reconstituted with C/EBPβ(-/-) bone marrow cells also significantly reduced blood cytokine levels and reduced lesion area in aortic sinuses compared with ApoE(-/-) mice reconstituted with WT bone marrow cells. Silencing of C/EBPβ in RAW264.7 macrophage cells prevented oxLDL-mediated foam cell formation and inflammatory cytokine secretion in conditioned medium. CONCLUSION: C/EBPβ in hematopoietic cells is crucial to regulate diet-induced inflammation, hyperlipidemia and atherosclerosis development.
BACKGROUND AND OBJECTIVE:Atherosclerosis is both a chronic inflammatory disease and a lipid metabolism disorder. C/EBPβ is well documented for its role in the development of hematopoietic cells and integration of lipid metabolism. However, C/EBPβ's role in atherosclerotic progression has not been examined. We assessed the impact of hematopoietic CEBPβ deletion in ApoE(-/-) mice on hyperlipidemia, inflammatory responses and lesion formation in the aorta. METHODS AND RESULTS:ApoE(-/-) mice were reconstituted with bone marrow cells derived from either WT or C/EBPβ(-/-) mice and placed on low fat or high fat/high cholesterol diet for 11 weeks. Hematopoietic C/EBPβ deletion in ApoE(-/-) mice reduced blood and hepatic lipids and gene expression of hepatic stearoyl CoA desaturase 1 and fatty acid synthase while expression of ATP binding cassette transporter G1, cholesterol 7-alpha-hydroxylase, and liver X receptor alpha genes were significantly increased. ApoE(-/-) mice reconstituted with C/EBPβ(-/-) bone marrow cells also significantly reduced blood cytokine levels and reduced lesion area in aortic sinuses compared with ApoE(-/-) mice reconstituted with WT bone marrow cells. Silencing of C/EBPβ in RAW264.7 macrophage cells prevented oxLDL-mediated foam cell formation and inflammatory cytokine secretion in conditioned medium. CONCLUSION:C/EBPβ in hematopoietic cells is crucial to regulate diet-induced inflammation, hyperlipidemia and atherosclerosis development.
Authors: Gary Bradshaw; Alejandra Gutierrez; Jon H Miyake; Kimberly R Davis; Andrew C Li; Christopher K Glass; Linda K Curtiss; Roger A Davis Journal: Proc Natl Acad Sci U S A Date: 2005-07-25 Impact factor: 11.205
Authors: Andreas Edsfeldt; Helena Grufman; Giuseppe Asciutto; Mihaela Nitulescu; Ana Persson; Marie Nilsson; Jan Nilsson; Isabel Gonçalves Journal: Atherosclerosis Date: 2015-06-03 Impact factor: 5.162
Authors: Shaikh M Rahman; Rachel C Janssen; Mahua Choudhury; Karalee C Baquero; Rebecca M Aikens; Becky A de la Houssaye; Jacob E Friedman Journal: J Biol Chem Date: 2012-08-19 Impact factor: 5.157
Authors: Nirupa R Matthan; Ann Giovanni; Ernst J Schaefer; B Greg Brown; Alice H Lichtenstein Journal: J Lipid Res Date: 2003-02-01 Impact factor: 5.922
Authors: Pingping Li; Nathanael J Spann; Minna U Kaikkonen; Min Lu; Da Young Oh; Jesse N Fox; Gautam Bandyopadhyay; Saswata Talukdar; Jianfeng Xu; William S Lagakos; David Patsouris; Aaron Armando; Oswald Quehenberger; Edward A Dennis; Steven M Watkins; Johan Auwerx; Christopher K Glass; Jerrold M Olefsky Journal: Cell Date: 2013-09-26 Impact factor: 41.582
Authors: Sam L Stephen; Katie Freestone; Sarah Dunn; Michael W Twigg; Shervanthi Homer-Vanniasinkam; John H Walker; Stephen B Wheatcroft; Sreenivasan Ponnambalam Journal: Int J Hypertens Date: 2010-08-17 Impact factor: 2.420
Authors: Yuan Tian; Bin Yang; Weinan Qiu; Yajing Hao; Zhenxing Zhang; Bo Yang; Nan Li; Shuqun Cheng; Zhangjun Lin; Yao-Cheng Rui; Otto K W Cheung; Weiqin Yang; William K K Wu; Yue-Sun Cheung; Paul B S Lai; Jianjun Luo; Joseph J Y Sung; Runsheng Chen; Hong-Yang Wang; Alfred S L Cheng; Pengyuan Yang Journal: Nat Commun Date: 2019-07-29 Impact factor: 14.919
Authors: Wang Yi-Bin; Li Xiang; Yang Bing; Zhang Qi; Jiao Fei-Tong; Wang Minghong; Zhang Xiangxiang; Kang Le; Li Yan; Sui Ping; Gao Yufei; Xu Ye; Wang Chun-Yan Journal: Cell Death Dis Date: 2022-04-07 Impact factor: 8.469